Analysts Set InfuSystem Holdings, Inc. (NYSE:INFU) PT at $14.50

Shares of InfuSystem Holdings, Inc. (NYSE:INFU) have been assigned an average recommendation of “Buy” from the five research firms that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating, two have issued a buy rating and two have issued a strong buy rating on the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $14.50.

Several equities research analysts recently weighed in on the company. Lake Street Capital began coverage on InfuSystem in a report on Monday, September 22nd. They set a “buy” rating and a $15.00 price target for the company. Roth Capital restated a “buy” rating and issued a $14.00 target price (up previously from $13.00) on shares of InfuSystem in a research note on Tuesday, November 4th. Finally, Zacks Research downgraded shares of InfuSystem from a “strong-buy” rating to a “hold” rating in a report on Monday, October 6th.

InfuSystem Stock Up 0.3%

InfuSystem stock opened at $9.28 on Thursday. The stock has a 50 day moving average of $9.87 and a two-hundred day moving average of $8.20. InfuSystem has a twelve month low of $4.61 and a twelve month high of $11.04. The stock has a market capitalization of $188.72 million, a price-to-earnings ratio of 154.69 and a beta of 1.80. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50.

Institutional Investors Weigh In On InfuSystem

Several institutional investors have recently made changes to their positions in the stock. CWM LLC boosted its stake in shares of InfuSystem by 1,160.1% during the 2nd quarter. CWM LLC now owns 4,826 shares of the company’s stock worth $30,000 after acquiring an additional 4,443 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in InfuSystem in the 2nd quarter worth approximately $33,000. Jump Financial LLC acquired a new position in InfuSystem in the first quarter valued at $58,000. Williams & Novak LLC purchased a new position in shares of InfuSystem during the 2nd quarter worth about $77,000. Finally, Virtu Financial LLC purchased a new position in InfuSystem during the first quarter worth approximately $86,000. 71.13% of the stock is currently owned by hedge funds and other institutional investors.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.